Old Web
English
Sign In
Acemap
>
Paper
>
Primary Results of the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase (CP) Chronic Myeloid Leukemia (CML)
Primary Results of the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase (CP) Chronic Myeloid Leukemia (CML)
2019
Carlo Gambacorti Passerini
Camille N. Abboud
Bjørn Tore Gjertsen
Tim H. Brümmendorf
B. Douglas Smith
Pilar Giraldo-Castellano
Ulla Strömberg
Susanne Saussele
Nathalie Bardy-Bouxin
Andrea Viqueira
Eric Leip
Jocelyn M Leone
Gianantonio Rosti
Justin M. Watts
Frank Giles
Andreas Hochhaus
Keywords:
Bosutinib
Cancer research
Immunology
Myeloid leukemia
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]